SCHEMBL14545272

SCHEMBL14545272

Bc1cnn2c(NCCCNS(=O)(=O)c3ccccc3S(N)(=O)=O)cc(-c3ccccc3O)nc12

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GSK3B P49841 6/20 0.36
▸ CDK2 P24941 8/20 0.35
▸ CCNA2 P20248 1/20 0.34
▸ CCNA1 P78396 1/20 0.34
▸ CA12 O43570 1/20 0.34
▸ CA2 P00918 1/20 0.34
▸ CA9 Q16790 1/20 0.34
▸ ALOX5AP P20292 3/20 0.33
▸ FEN1 P39748 3/20 0.33
▸ KDM4E B2RXH2 1/20 0.33
▸ NPC1 O15118 1/20 0.33
▸ MAPT P10636 1/20 0.33
▸ MAPK1 P28482 1/20 0.33
▸ RAB9A P51151 1/20 0.33
▸ GFER P55789 1/20 0.33
▸ NPSR1 Q6W5P4 1/20 0.33
▸ CCNE1 P24864 1/20 0.33
▸ MEN1 O00255 1/20 0.32
▸ KMT2A Q03164 1/20 0.32
▸ NPY5R Q15761 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14613413 0.89 GSK3B (0.36) GSK3BCDK2CCNA2CCNA1KDM4E
SCHEMBL14613281 0.86 GSK3B (0.37) GSK3BCDK2CCNA2CCNA1KDM4E
SCHEMBL12954494 0.86 GSK3B (0.42) GSK3BCDK2CCNA2CCNA1ALOX5AP
SCHEMBL12953984 0.85 NPY5R (0.41) CDK2KDM4EMEN1KMT2ANPY5R
SCHEMBL13288981 0.85 CDK2 (0.46) GSK3BCDK2CCNA2CCNA1KDM4E
SCHEMBL14613411 0.83 GSK3B (0.33) GSK3BCDK2CCNA2CCNA1KDM4E
SCHEMBL13289301 0.83 CDK2 (0.46) GSK3BCDK2KDM4ENPC1MAPT
SCHEMBL14613280 0.83 MEN1 (0.45) GSK3BCDK2CCNA2CCNA1KDM4E
SCHEMBL13289056 0.82 F13A1 (0.36) GSK3BCDK2CCNA2CCNA1KDM4E
SCHEMBL13289271 0.82 MMP2 (0.44) GSK3BCA12CA2CA9MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2007044449-A2 NOVEL PYRAZOLOPYRIMIDINES AS CYCLIN DEPENDENT KINASE INHIBITORS SCHERING CORPORATION (US) 2007-04-19 — — WO disclosed
Send feedback